Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kangzhong Times is a Chinese clinical research service provider that specializes in oncology and chronic disease management. The company integrates Site Management Organization (SMO) and Contract Research Organization (CRO) services with advanced digital healthcare technology to streamline drug development. Their core business includes patient recruitment, clinical trial management, and the collection of real-world evidence through proprietary digital platforms. By bridging the gap between pharmaceutical sponsors, clinical sites, and patients, Kangzhong Times focuses on improving the efficiency and success rates of clinical investigations in China. The company is particularly recognized for its extensive network of hospital partnerships and its ability to handle complex trials in high-incidence disease areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangzhong Times.